PedAM
Pediatric Disease Annotations & Medicines
| Disease | optic pathway glioma |
| Phenotype | C0085113|neurofibromatosis |
| Sentences | 9 |
| PubMedID- 21168074 | Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. |
| PubMedID- 21232732 | Design: cross-sectional convenience sample, with prospective data collection, from a tertiary care children's hospital of patients with optic pathway gliomas associated with neurofibromatosis type 1, sporadic optic pathway gliomas, and neurofibromatosis type 1 without optic pathway gliomas. |
| PubMedID- 26294105 | Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. |
| PubMedID- 20451859 | optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. |
| PubMedID- 26233602 | The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. |
| PubMedID- 24101736 | Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1. |
| PubMedID- 21822956 | Therefore, the aim of our study was to find a clinical indicator for the presence of optic pathway gliomas in children with neurofibromatosis type 1 in order to facilitate early diagnosis and initiate further ophthalmological and neuroimaging investigations. |
| PubMedID- 21274014 | Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. |
| PubMedID- 24488155 | Purpose: to compare the optical coherence tomography (oct) findings of neurofibromatosis-1 (nf-1) patients with/without optic pathway glioma (opg) with those of healthy controls. |
Page: 1